Login / Signup

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.

Naoyuki NogamiTakaaki TokitoYoshitaka ZenkeMiyako SatouchiTakashi SetoHideo SakaJunko OhtaniShirong HanKazuo NoguchiMakoto Nishio
Published in: Investigational new drugs (2024)
ClinicalTrials.gov , NCT01840579.
Keyphrases
  • small cell lung cancer
  • open label
  • advanced non small cell lung cancer
  • locally advanced
  • brain metastases
  • double blind
  • placebo controlled
  • clinical trial
  • chemotherapy induced
  • epidermal growth factor receptor